Dongwha Pharm.Co.,Ltd

Symboli: 000020.KS

KSC

8750

KRW

Markkinahinta tänään

  • 8.7584

    P/E-suhde

  • 0.0387

    PEG-suhde

  • 242.53B

    MRK Cap

  • 0.02%

    DIV Tuotto

Dongwha Pharm.Co.,Ltd (000020-KS) Tilinpäätöstiedotteet

Kaaviossa näet oletusarvot Dongwha Pharm.Co.,Ltd (000020.KS). Yrityksen liikevaihto näyttää NaN M keskiarvon, joka on NaN % gowth. Koko jakson keskimääräinen bruttovoitto on NaN M, joka on NaN %. Keskimääräinen bruttovoittosuhde on NaN %. Yrityksen viime vuoden tuloksen nettotuloksen kasvu on NaN %, joka on NaN % % keskimäärin koko yrityksen historian aikana.,

Tase

Dongwha Pharm.Co.,Ltd verotukselliseen kehitykseen sukeltamalla havaitsemme keskimääräisen varallisuuden kasvun. Tämä korko on mielenkiintoisesti , mikä heijastaa sekä yrityksen huippuja että matalimpia lukemia. Neljännesvuosittaisessa vertailussa tämä luku on . Kun tarkastellaan viime vuotta taaksepäin, kokonaisvarojen muutos on NaN. Osakkeenomistajien arvo, jota kuvaa osakepääoman kokonaismäärä, arvostetaan NaN raportointivaluutassa. Tämän näkökohdan vuosittainen muutos on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

balance-sheet.row.cash-and-short-term-investments

087234.2107694.5121509.6
120330.8
120018.9
103681.9
129681.4
66750.4
50909.4
35678.7
31184.1
34139.2
37054.4
20482.6
16779
57455.8
60390.3

balance-sheet.row.short-term-investments

014917.173347.461030
61734.4
82239.8
63067.4
98093.3
31020
6020
3055.5
3020
16020
1920
2341.6
7262.8
52778.5
50961.6

balance-sheet.row.net-receivables

074484.372638.262266.7
62773.2
81837.6
80247
68212.4
58164.1
57954.4
56486.7
55138.9
55501.9
63104.1
61067.2
51125.3
52688.3
54745.5

balance-sheet.row.inventory

070697.246783.636244
39504.2
33430.8
43717.6
36606.2
26577.3
26150.9
28382.3
30436.8
31594.4
32162.7
39026.8
37446.8
26225.3
17717

balance-sheet.row.other-current-assets

05284.4411.1178.3
135.2
169.7
240.9
0
0
0
0
0.2
0.2
0.2
0.2
0.2
0.2
0.2

balance-sheet.row.total-current-assets

0237700227527.5220198.6
222743.5
235457
227887.5
234500
151491.8
135014.7
120547.7
116759.9
121235.7
132321.4
120576.9
105351.2
136369.7
132852.9

balance-sheet.row.property-plant-equipment-net

0188330.5151152.7142850.5
130950.8
99214.8
96772.5
103746.3
142170.9
151777.3
161854.1
171902.3
183871.6
188283.8
149283.6
154301.7
71262.7
53292.6

balance-sheet.row.goodwill

020483.34555.84555.8
4555.8
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

035994.511146.713582.4
12417
5464.7
5581.2
6137
6442.3
6431.8
7107.6
8265.3
4194.7
5222.6
5292.3
4574.2
1109.4
904.5

balance-sheet.row.goodwill-and-intangible-assets

056477.815702.518138.2
16972.8
5464.7
5581.2
6137
6442.3
6431.8
7107.6
8265.3
4194.7
5222.6
5292.3
4574.2
1109.4
904.5

balance-sheet.row.long-term-investments

073880.1-16766.6-9737.1
-11957
-52000.1
-26567.7
-76135.4
-9620.9
10668.9
14883.6
11452.3
-1684.3
11036.8
10032.5
6383.5
-42829.7
-41631.3

balance-sheet.row.tax-assets

06241.864006194.2
3965.6
5652.4
3858.4
883.8
3100.3
7274.4
5624.5
4117.8
16666.9
2566.9
1265
74.1
0
52196.6

balance-sheet.row.other-non-current-assets

02342.277120.470160
71132.1
82239.8
63067.4
98093.3
31020
6020
3055.5
3667.9
0
0
37559.6
38307.1
54510.9
333.1

balance-sheet.row.total-non-current-assets

0327272.4233609227605.8
211064.3
140571.6
142711.8
132725.1
173112.7
182172.3
192525.4
199405.6
203049
207110.1
203433
203640.5
84053.3
65095.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0564972.4461136.5447804.5
433807.8
376028.6
370599.2
367225.1
324604.5
317187
313073.1
316165.5
324284.7
339431.5
324009.9
308991.7
220423
197948.4

balance-sheet.row.account-payables

031412.322231.817118.7
18522.2
17322.5
29965.4
21776.3
25671.9
17169.6
17980.1
18495.6
17645.5
22057
17923.1
16552.6
6778.5
4789.1

balance-sheet.row.short-term-debt

020371.54619.76418.5
11614.3
1793.2
0
0
0
2000
4000
4000
10000
18500
24250
31626
5825
8596.4

balance-sheet.row.tax-payables

02224.55443.87788.1
8607.2
10332.8
5101.6
16384
6055.3
3657.9
3216.6
6404.9
11585.5
3065.5
5896.5
1799.7
13505.5
7065.7

balance-sheet.row.long-term-debt-total

016127.72044.35055.7
4074.5
5116
0
0
0
0
0
2000
0
10000
18500
0
336.8
1161.8

Deferred Revenue Non Current

011756.122.940.5
16775.1
0
0
0
0
0
0
0
0
30162.2
6771.7
0
10013
7792

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

052909.447508.85988.9
5940.2
6927.8
30832.9
38940.4
29780.1
0
0
0
0
0
40484.5
44506.4
0
0

balance-sheet.row.total-non-current-liabilities

0515236900.921210
23631.6
19439.3
12400.3
9563.8
16227.2
17920.2
14432.2
15561.8
14690.1
21947.4
27437.3
7427.7
8703.3
11894.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

011756.13686.83514.6
5888.8
6909.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0157656.982463.287671.3
91125.6
75154
73198.6
70280.4
71679.2
87069.3
83347.3
88934.4
97290
109807.6
110094.9
100112.7
41281.1
36950.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

027931.527931.527931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5
27931.5

balance-sheet.row.retained-earnings

034480.7311972.2290329
270244.8
198844.7
195595.4
239897.6
197195.9
174195.4
173103.7
170147.3
169661.3
172752.3
119334.3
113223.5
86087.7
67944

balance-sheet.row.accumulated-other-comprehensive-income-loss

0293197.7274806261485.5
246425.1
236228.7
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

016169.6-250309.3-232811.1
-213345.8
-162130.2
73564.1
29115.6
27797.9
27990.9
28690.6
29152.3
29401.9
28940.1
66649.3
67724.1
65122.8
65122.7

balance-sheet.row.total-stockholders-equity

0371779.5364400.4346934.9
331255.5
300874.6
297091
296944.7
252925.3
230117.7
229725.8
227231.1
226994.7
229623.9
213915
208879.1
179141.9
160998.2

balance-sheet.row.total-liabilities-and-stockholders-equity

0564972.4461136.5447804.5
433807.8
376028.6
370599.2
367225.1
324604.5
317187
313073.1
316165.5
324284.7
339431.5
324009.9
308991.7
220423
197948.4

balance-sheet.row.minority-interest

03553614272.813198.3
11426.7
0
309.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0407315.5378673.3360133.2
342682.2
300874.6
297400.7
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

088797.156580.951292.9
49777.4
30239.7
36499.8
21957.9
21399.1
16688.9
17939.1
14472.3
14335.7
12956.8
12374.1
13646.4
9948.8
9330.3

balance-sheet.row.total-debt

048255.4666411474.1
15688.8
6909.2
0
0
0
2000
4000
6000
10000
28500
42750
31626
6161.8
9758.1

balance-sheet.row.net-debt

0-24061.8-27683.1-49005.5
-42907.6
-30869.9
-40614.5
-31588.2
-35730.4
-42889.4
-28623.2
-22164.1
-8119.2
-6634.4
24609
22109.8
1484.4
329.5

Kassavirtalaskelma

Dongwha Pharm.Co.,Ltd taloudessa on tapahtunut huomattava muutos vapaan kassavirran määrässä viimeisen ajanjakson aikana, ja se on muuttunut NaN suuntaan. Yhtiö on hiljattain laajentanut osakepääomaansa laskemalla liikkeeseen NaN, mikä merkitsee NaN eroa edelliseen vuoteen verrattuna. Yhtiön investointitoiminnasta aiheutui nettokassan käyttöä, joka oli NaN raportointivaluutassa. Tämä on NaN siirtymä edellisestä vuodesta. Samana ajanjaksona yhtiö kirjasi NaN, NaN ja NaN, jotka ovat merkittäviä yrityksen investointi-ja takaisinmaksustrategioiden ymmärtämisen kannalta. Yhtiön rahoitustoiminta johti siihen, että nettokassan käyttö oli NaN, ja ero edellisvuoteen oli {{year_over_year_net_cash_from_financing_activities_change_percentage}}. Lisäksi yhtiö osoitti NaN osingonjakoon osakkeenomistajilleen. Samaan aikaan se toteutti myös muita rahoitusmanöövereitä, joihin viitataan nimellä {{other-financing-activities}}, jotka myös vaikuttivat merkittävästi sen kassavirtaan kyseisenä ajanjaksona. Nämä osatekijät muodostavat yhdessä kattavan kuvan yrityksen taloudellisesta tilanteesta ja strategisesta lähestymistavasta kassavirran hallintaan.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

cash-flows.row.net-income

027438.321591.219582.8
28715.1
9393.9
10068.1
47009
26254.3
5608.7
4937.2
1011.9
1311.2
17679.2
5427.2
6717.4
21495.4
8065.2

cash-flows.row.depreciation-and-amortization

01389612509.112093
10707
11484.7
11357.2
11501.1
11743.7
11864.5
12636.7
12532.2
12201
12457
18732.6
15228.1
3473.8
3320.2

cash-flows.row.deferred-income-tax

0-41674.500
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

076.100
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-19296.7-18086.3-4035.4
11363.9
-17040.7
-23576
-41682.8
-25687.1
-4417.2
-8506.8
-592.6
-2306.8
14883.4
-12149.8
5381.5
-7219.1
7894.5

cash-flows.row.account-receivables

0-4300.7-5636750.8
24046
-1972.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-12307.6-14104.5-1443.4
-5580.6
4451.4
-11789
-13584.4
-2881.9
-684
-1945.2
1157.7
568.3
4965.7
-3170.4
3925.9
-8508.4
-706.3

cash-flows.row.account-payables

02801.95014.1-1532.4
436.5
-12642.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-5490.3-3359.9-1810.4
-7538
-6877.1
-11787
-28098.3
-22805.2
-3733.2
-6561.6
-1750.3
-2875
9917.8
-8979.4
1455.5
1289.2
8600.8

cash-flows.row.other-non-cash-items

048727.413206.78390.8
1442.2
9447.2
-2209.4
-33347.3
13171.2
6777.2
4447.6
-4746.4
14021.3
1224.4
6577.9
2593.4
5905.3
3906

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-26345.6-20091.5-24774.2
-30114.7
-5505.8
-3701.4
-3370.3
-2503.1
-1225.9
-1684.7
-5881.6
-6844.8
-9783.2
-12571.8
-35004.1
-22170.3
-6479.9

cash-flows.row.acquisitions-net

0-18896.42599.2-2070.4
-18180.3
15195.4
243.6
-1000
-1408.9
-358.9
-408.1
-1675.9
0
-430.4
408.9
2044.8
464.5
-181.7

cash-flows.row.purchases-of-investments

0-27918.4-143537.9-105847.9
-82249.3
-101955.1
-40607.6
-85300.1
-30500
0
-3035.5
-3020
-14100
-22262.3
-2130.5
-53276.7
-117573.3
-81980.3

cash-flows.row.sales-maturities-of-investments

076140.5114969.9104048.7
100748.9
81117.8
61524.4
21041.8
2508.8
223.2
50
16039
0
22097.7
7313.8
68968.7
115209.5
69012.8

cash-flows.row.other-investing-activites

0-117.32788.33230
3964.6
-30.7
-241.6
84938.6
1474.3
381.9
-20.8
2616.8
0
948.8
-1391.5
1175.4
124.3
-545.4

cash-flows.row.net-cash-used-for-investing-activites

02863-43272-25413.9
-25830.8
-11178.4
17217.4
16310
-30429
-979.7
-5099.1
8078.4
-20944.8
-9429.4
-8371.2
-16091.8
-23945.4
-20174.5

cash-flows.row.debt-repayment

0-13500-7500-7800
-1000
0
0
0
-2000
-2000
-2000
-8000
-18500
-27029
-35000
-2336.8
-3596.4
-3596.4

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
-876.5
0
-2354.4
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-4982.2-4982.2-4969.4
-3312.9
-3312.9
-4141.2
-3043.1
-2213.2
-2234.5
-1955.2
-2234.5
-2793.1
-2793.1
-2793.1
-4189.7
-3351.7
-2793.1

cash-flows.row.other-financing-activites

024347.7469.23986.5
-1145.1
-1624.6
310
0
0
0
0
4000
0
10000
36201.3
-8753.2
2487
610.7

cash-flows.row.net-cash-used-provided-by-financing-activities

05865.5-12013-8782.9
-5458.1
-4937.6
-3831.2
-3919.6
-4213.2
-6588.9
-3955.2
-6234.5
-21293.1
-19822.2
-1591.8
-15279.6
-4461.2
-5778.8

cash-flows.row.effect-of-forex-changes-on-cash

074.9-68.248.8
-122.1
-4.3
0.2
-12.6
1
1.7
-1.2
-4.1
-4
1
0
0
0
0

cash-flows.row.net-change-in-cash

037970-26132.51883.2
20817.2
-2835.3
9026.3
-4142.2
-9159
12266.2
4459.1
10044.9
-17015.2
16993.4
8624.8
-1451.1
-4751.2
-2767.4

cash-flows.row.cash-at-end-of-period

072317.134347.160479.6
58596.4
37779.2
40614.5
31588.2
35730.4
44889.4
32623.2
28164.1
18119.2
35134.4
18141
9516.2
4677.4
9428.6

cash-flows.row.cash-at-beginning-of-period

034347.160479.658596.4
37779.2
40614.5
31588.2
35730.4
44889.4
32623.2
28164.1
18119.2
35134.4
18141
9516.2
10967.3
9428.6
12196

cash-flows.row.operating-cash-flow

029166.629220.836031.2
52228.2
13285
-4360.1
-16520
25482.2
19833.1
13514.7
8205.1
25226.8
46244
18587.8
29920.3
23655.3
23185.9

cash-flows.row.capital-expenditure

0-26345.6-20091.5-24774.2
-30114.7
-5505.8
-3701.4
-3370.3
-2503.1
-1225.9
-1684.7
-5881.6
-6844.8
-9783.2
-12571.8
-35004.1
-22170.3
-6479.9

cash-flows.row.free-cash-flow

028219129.311257
22113.5
7779.1
-8061.5
-19890.3
22979.1
18607.2
11829.9
2323.6
18382
36460.8
6016
-5083.7
1485
16706

Tuloslaskelmarivi

Dongwha Pharm.Co.,Ltd liikevaihto muuttui NaN% edelliseen kauteen verrattuna. 000020.KS:n bruttovoitto ilmoitetaan NaN. Yrityksen toimintakulut ovat NaN, ja niissä on tapahtunut NaN%:n muutos edelliseen vuoteen verrattuna. Poistojen ja arvonalentumisten kulut ovat NaN, mikä on NaN% muutos edellisestä tilikaudesta. Toimintakulujen ilmoitetaan olevan NaN, mikä osoittaa NaN%:n muutoksen edellisvuoteen verrattuna. Myynti- ja markkinointikulut ovat NaN, mikä on NaN% muutos edelliseen vuoteen verrattuna. Viimeisimpiin lukuihin perustuva käyttökate on NaN, mikä vastaa NaN%:n kasvua edellisvuoteen verrattuna. Liikevoitto on NaN, joka osoittaa NaN%:n muutosta edelliseen vuoteen verrattuna. Nettotuloksen muutos on NaN%. Viime vuoden nettotulos oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920072006

income-statement-row.row.total-revenue

0361108.6340426.3293018.1
272075.4
307150
306602.6
258881.6
237470.8
223201.3
213472.1
220240.6
223372
234562
215279.4
145115.2
175119.8
148738.6

income-statement-row.row.cost-of-revenue

0176983.8159436.1143671.1
133409.4
185418.3
190699.4
150798
134293.4
126621.9
118268.2
124566.9
124599.3
126631.7
121482.7
79597.7
77654.1
76044.8

income-statement-row.row.gross-profit

0184124.7180990.3149347
138666
121731.7
115903.2
108083.6
103177.4
96579.4
95203.9
95673.7
98772.7
107930.3
93796.7
65517.4
97465.6
72693.8

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-342332.755166.453095.9
47771.6
46097.2
400.8
-1669.5
21730.5
133.8
-2801.1
-2303.2
-2310.2
-5680.1
-4513.8
-2105.4
-4623.2
-3074.3

income-statement-row.row.operating-expenses

0342332.7151075.2126848.5
115508.7
111814
104674.1
97096.3
91918.1
91766.4
87409.6
93611.5
88769.8
82308.6
83479.5
53129.2
63920.8
58522.5

income-statement-row.row.cost-and-expenses

0342332.7310511.2270519.6
248918.1
297232.3
295373.4
247894.3
226211.5
218388.3
205677.9
218178.4
213369.1
208940.3
204962.2
132726.9
141574.9
134567.4

income-statement-row.row.interest-income

03252.82387.71067.9
1839.7
1942.7
2116.7
1166.8
856.9
786.1
896.4
926.2
1376.7
669.9
989.5
1008.7
4055.6
2834.7

income-statement-row.row.interest-expense

0308370383.1
292.2
207
-3685.5
-108755.7
7.7
136.7
231.6
384.3
1056
1757.6
2446.4
1303
447.7
624.8

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

018179.7-6829.54030.9
10484.9
-487.1
3313.3
54231.4
1234.6
1187.6
-507
-354.9
-1573.3
-6588.6
-1658.8
-412.6
-673.7
-651.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-342332.755166.453095.9
47771.6
46097.2
400.8
-1669.5
21730.5
133.8
-2801.1
-2303.2
-2310.2
-5680.1
-4513.8
-2105.4
-4623.2
-3074.3

income-statement-row.row.total-operating-expenses

018179.7-6829.54030.9
10484.9
-487.1
3313.3
54231.4
1234.6
1187.6
-507
-354.9
-1573.3
-6588.6
-1658.8
-412.6
-673.7
-651.5

income-statement-row.row.interest-expense

0308370383.1
292.2
207
-3685.5
-108755.7
7.7
136.7
231.6
384.3
1056
1757.6
2446.4
1303
447.7
624.8

income-statement-row.row.depreciation-and-amortization

0138961398114940.8
12080.6
11484.7
11357.2
11501.1
11743.7
11864.5
12636.7
12532.2
12201
12457
18732.6
15228.1
3473.8
3320.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

018775.929915.122496.4
23153.4
17095
11225.8
10987.3
11259.3
4813
7794.3
2062.2
10002.9
25621.7
10317.2
12388.3
33544.8
14171.3

income-statement-row.row.income-before-tax

036955.623085.526527.3
33638.3
16607.9
14539.1
65218.7
35655.1
6000.6
5401.9
889.9
8429.6
19033.1
5430.2
11975.6
32871.2
13519.8

income-statement-row.row.income-tax-expense

08718.51494.36944.5
4923.2
7214
4470.9
18209.7
9400.8
392
464.7
-122
7118.4
1353.9
3
5258.2
11375.8
5454.6

income-statement-row.row.net-income

027438.320383.517870.4
28507.7
9402.2
10068.5
47009
26254.3
5608.7
4937.2
1011.9
1311.2
17679.2
5427.2
6717.4
21495.4
8065.2

Usein kysytty kysymys

Mikä on Dongwha Pharm.Co.,Ltd (000020.KS) taseen loppusumma?

Dongwha Pharm.Co.,Ltd (000020.KS) kokonaisvarat ovat 564972408621.000.

Mikä on yrityksen vuotuinen liikevaihto?

Vuotuinen liikevaihto on N/A.

Mikä on yrityksen voittomarginaali?

Yrityksen voittomarginaali on 0.523.

Mikä on yrityksen vapaa kassavirta?

Vapaa kassavirta on 101.776.

Mikä on yrityksen nettovoittomarginaali?

Nettovoittomarginaali on 0.076.

Mikä on yrityksen kokonaistulot?

Kokonaisliikevaihto on 0.052.

Mikä on Dongwha Pharm.Co.,Ltd (000020.KS) nettovoitto (nettotulos)?

Nettovoitto (nettotulos) on 27438289760.000.

Mikä on yrityksen kokonaisvelka?

Kokonaisvelka on 48255358875.000.

Mikä on yrityksen toimintakulujen määrä?

Toimintakulut ovat 342332682000.000.

Mikä on yrityksen kassan määrä?

Yrityksen kassavarat ovat 0.000.